Back

The prognostic interplay of heart failure and chronic kidney disease in atrial fibrillation, focus on cardiorenal outcomes

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Management of comorbidities and outcomes in atrial fibrillation (1) Heart Failure in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Ulrike Baumer

Medical University of Vienna, Vienna (Austria)

7 More presentations in this session

Presentation thumbnail
Semaglutide and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials
Doctor G. Costa (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Insights into type 2 diabetes mellitus in atrial fibrillation patients: a proteomics approach
Miss N. Atzemian (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Inflammation and long-term outcomes after first-time direct current cardioversion for atrial fibrillation: a nationwide register study
Doctor A. Langhoff (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial aibrillation: a report from 2 prospective observational registries
Doctor J. Imberti (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Risk of embolic events in patients with Chagasic Cardiomyopathy and Atrial Fibrillation despite antithrombotic therapy: is anticoagulation enough?
Doctor L. Echeverria (Floridablanca, CO)
Abstract Slides

Access the full session

Session thumbnail
Management of comorbidities and outcomes in atrial fibrillation (1)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Adherence to the Atrial Fibrillation Better Care (ABC) pathway and outcomes in patients with chronic kidney disease: A report from the APHRS-AF registry.
thumbnail
Congress Presentation
Clinical impact of kidney function in patients with atrial fibrillation receiving oral anticoagulants
thumbnail
Congress Presentation
Outcomes of atrial fibrillation ablation in patients with chronic kidney disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources